Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Growth (Status and Outlook) 2022-2028

  • LP 4922695
  • 88 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform will have significant change from previous year. According to our (LP Information) latest study, the global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market, reaching US$ million by the year 2028. As for the Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform players cover AstraZeneca Plc, Bayer AG, Curis Inc, and GlaxoSmithKline Plc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

PQR-514

KA-2237

GSK-2636771

BAY-1082439

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Gastric Cancer

Metastatic Colorectal Cancer

Myelofibrosis

Renal Cell Carcinoma

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

AstraZeneca Plc

Bayer AG

Curis Inc

GlaxoSmithKline Plc

Karus Therapeutics Ltd

Novartis AG

PIQUR Therapeutics AG

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2017-2028

2.1.2 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Segment by Type

2.2.1 PQR-514

2.2.2 KA-2237

2.2.3 GSK-2636771

2.2.4 BAY-1082439

2.2.5 Others

2.3 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Type

2.3.1 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Type (2017-2022)

2.4 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Segment by Application

2.4.1 Gastric Cancer

2.4.2 Metastatic Colorectal Cancer

2.4.3 Myelofibrosis

2.4.4 Renal Cell Carcinoma

2.4.5 Others

2.5 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Application

2.5.1 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Application (2017-2022)

3 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Player

3.1 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Players

3.1.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Players (2020-2022)

3.1.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Players (2020-2022)

3.2 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform by Regions

4.1 Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Regions (2017-2022)

4.2 Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth (2017-2022)

4.3 APAC Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth (2017-2022)

4.4 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth (2017-2022)

4.5 Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth (2017-2022)

5 Americas

5.1 Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2017-2022)

5.2 Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Type (2017-2022)

5.3 Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region (2017-2022)

6.2 APAC Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Type (2017-2022)

6.3 APAC Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform by Country (2017-2022)

7.2 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Type (2017-2022)

7.3 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform by Region (2017-2022)

8.2 Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Type (2017-2022)

8.3 Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecast by Regions (2023-2028)

10.1.1 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecast by Regions (2023-2028)

10.1.2 Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecast

10.1.3 APAC Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecast

10.1.4 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecast

10.1.5 Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecast

10.2 Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecast by Country (2023-2028)

10.2.1 United States Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.2.2 Canada Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.2.3 Mexico Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.2.4 Brazil Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.3 APAC Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecast by Region (2023-2028)

10.3.1 China Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.3.2 Japan Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.3.3 Korea Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.3.4 Southeast Asia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.3.5 India Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.3.6 Australia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.4 Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecast by Country (2023-2028)

10.4.1 Germany Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.4.2 France Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.4.3 UK Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.4.4 Italy Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.4.5 Russia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.5 Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecast by Region (2023-2028)

10.5.1 Egypt Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.5.2 South Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.5.3 Israel Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.5.4 Turkey Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.5.5 GCC Countries Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Forecast

10.6 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecast by Type (2023-2028)

10.7 Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 AstraZeneca Plc

11.1.1 AstraZeneca Plc Company Information

11.1.2 AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Offered

11.1.3 AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 AstraZeneca Plc Main Business Overview

11.1.5 AstraZeneca Plc Latest Developments

11.2 Bayer AG

11.2.1 Bayer AG Company Information

11.2.2 Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Offered

11.2.3 Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Bayer AG Main Business Overview

11.2.5 Bayer AG Latest Developments

11.3 Curis Inc

11.3.1 Curis Inc Company Information

11.3.2 Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Offered

11.3.3 Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Curis Inc Main Business Overview

11.3.5 Curis Inc Latest Developments

11.4 GlaxoSmithKline Plc

11.4.1 GlaxoSmithKline Plc Company Information

11.4.2 GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Offered

11.4.3 GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 GlaxoSmithKline Plc Main Business Overview

11.4.5 GlaxoSmithKline Plc Latest Developments

11.5 Karus Therapeutics Ltd

11.5.1 Karus Therapeutics Ltd Company Information

11.5.2 Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Offered

11.5.3 Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Karus Therapeutics Ltd Main Business Overview

11.5.5 Karus Therapeutics Ltd Latest Developments

11.6 Novartis AG

11.6.1 Novartis AG Company Information

11.6.2 Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Offered

11.6.3 Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Novartis AG Main Business Overview

11.6.5 Novartis AG Latest Developments

11.7 PIQUR Therapeutics AG

11.7.1 PIQUR Therapeutics AG Company Information

11.7.2 PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Offered

11.7.3 PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 PIQUR Therapeutics AG Main Business Overview

11.7.5 PIQUR Therapeutics AG Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of PQR-514

Table 3. Major Players of KA-2237

Table 4. Major Players of GSK-2636771

Table 5. Major Players of BAY-1082439

Table 6. Major Players of Others

Table 7. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Type (2017-2022)

Table 10. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Application (2017-2022)

Table 13. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Player (2020-2022)

Table 15. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Key Players Head office and Products Offered

Table 16. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Regions (2017-2022)

Table 21. Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Country (2017-2022)

Table 23. Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Type (2017-2022)

Table 25. Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Application (2017-2022)

Table 27. APAC Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Region (2017-2022)

Table 29. APAC Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Type (2017-2022)

Table 31. APAC Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Application (2017-2022)

Table 33. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Country (2017-2022)

Table 35. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Type (2017-2022)

Table 37. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform

Table 46. Key Market Challenges & Risks of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform

Table 47. Key Industry Trends of Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform

Table 48. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share Forecast by Application (2023-2028)

Table 54. AstraZeneca Plc Details, Company Type, Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Area Served and Its Competitors

Table 55. AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Offered

Table 56. AstraZeneca Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. AstraZeneca Plc Main Business

Table 58. AstraZeneca Plc Latest Developments

Table 59. Bayer AG Details, Company Type, Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Area Served and Its Competitors

Table 60. Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Offered

Table 61. Bayer AG Main Business

Table 62. Bayer AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Bayer AG Latest Developments

Table 64. Curis Inc Details, Company Type, Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Area Served and Its Competitors

Table 65. Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Offered

Table 66. Curis Inc Main Business

Table 67. Curis Inc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Curis Inc Latest Developments

Table 69. GlaxoSmithKline Plc Details, Company Type, Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Area Served and Its Competitors

Table 70. GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Offered

Table 71. GlaxoSmithKline Plc Main Business

Table 72. GlaxoSmithKline Plc Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. GlaxoSmithKline Plc Latest Developments

Table 74. Karus Therapeutics Ltd Details, Company Type, Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Area Served and Its Competitors

Table 75. Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Offered

Table 76. Karus Therapeutics Ltd Main Business

Table 77. Karus Therapeutics Ltd Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Karus Therapeutics Ltd Latest Developments

Table 79. Novartis AG Details, Company Type, Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Area Served and Its Competitors

Table 80. Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Offered

Table 81. Novartis AG Main Business

Table 82. Novartis AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Novartis AG Latest Developments

Table 84. PIQUR Therapeutics AG Details, Company Type, Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Area Served and Its Competitors

Table 85. PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Product Offered

Table 86. PIQUR Therapeutics AG Main Business

Table 87. PIQUR Therapeutics AG Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. PIQUR Therapeutics AG Latest Developments

List of Figures

Figure 1. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Type in 2021

Figure 7. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform in Gastric Cancer

Figure 8. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market: Gastric Cancer (2017-2022) & ($ Millions)

Figure 9. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform in Metastatic Colorectal Cancer

Figure 10. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market: Metastatic Colorectal Cancer (2017-2022) & ($ Millions)

Figure 11. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform in Myelofibrosis

Figure 12. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market: Myelofibrosis (2017-2022) & ($ Millions)

Figure 13. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform in Renal Cell Carcinoma

Figure 14. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market: Renal Cell Carcinoma (2017-2022) & ($ Millions)

Figure 15. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform in Others

Figure 16. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Application in 2021

Figure 18. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Revenue Market Share by Player in 2021

Figure 19. Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2017-2022 ($ Millions)

Figure 21. APAC Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2017-2022 ($ Millions)

Figure 22. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2017-2022 ($ Millions)

Figure 24. Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Value Market Share by Country in 2021

Figure 25. Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Consumption Market Share by Type in 2021

Figure 26. Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Application in 2021

Figure 27. United States Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Region in 2021

Figure 32. APAC Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Application in 2021

Figure 33. China Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Country in 2021

Figure 40. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Type in 2021

Figure 41. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Application in 2021

Figure 42. Germany Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Market Share by Application in 2021

Figure 50. Egypt Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 56. APAC Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 57. Europe Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 59. United States Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 60. Canada Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 63. China Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 64. Japan Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 65. Korea Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 67. India Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 68. Australia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 69. Germany Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 70. France Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 71. UK Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 72. Italy Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 73. Russia Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 74. Spain Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 77. Israel Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390